AI-360
Autonomous AI agents work behind the scenes without constant human supervision. Companies using Agentforce achieve ROI 5x faster than custom-built alternatives.
Sofya deployed Llama models with knowledge distillation techniques, reducing provider documentation time by 30% while maintaining 90% customer satisfaction.
The marketplace debuts with 200+ partners offering pre-built AI components, addressing a key bottleneck in enterprise AI adoption—time and expertise to build capabilities.
The system automates converting meeting transcripts to PRDs and development tickets using specialized agents powered by Mistral Large 2, eliminating manual effort.
Med-Gemini, a multimodal model fine-tuned on de-identified medical data, achieves 91.1% accuracy on medical licensing exams and interprets 3D scans.
Anthropic's Claude 3.7 Sonnet sets new benchmarks in coding abilities. Novo Nordisk uses it to reduce clinical report writing from 12 weeks to 10 minutes.
Claude 3.7 Sonnet, the first hybrid reasoning model, will be tested by scientists to compress decades of scientific progress into shorter timeframes.
Research shows AI can accelerate education innovation by simulating interventions before human evaluation—potentially reducing timelines from decades to years.
GPT-4.5 achieves 62.5% accuracy on SimpleQA evaluation and reduces hallucination rates to 37.1%, compared to GPT-4o's 61.8% hallucination rate.
Salesforce's help.salesforce.com implementation handled 380,000 customer service conversations with an 84% resolution rate, with only 2% requiring humans.
Claude 3.7 Sonnet is both an ordinary LLM and a reasoning model in one: you can pick when you want the model to answer normally or think longer.
The integration enables multi-modal capabilities by incorporating Gemini's ability to process images, audio, and video alongside text with a 2M-token context window.
The study identified three critical success factors: jurisdictional clarity, task centrality, and task homogeneity in organizational AI implementations.
Meta's open-source AI models enable 26.8% higher cancer treatment prediction accuracy and reduce clinical trial matching from hundreds of days to just one day.
Grok 3's 'Think' capability exposes its full reasoning process, allowing users to inspect how it explores alternatives and corrects errors, addressing AI explainability demands.